Colposcopy Market Size, Share, Growth, and Industry Analysis, By Type (Electronic Colposcopy, Optical Colposcopy), By Application (Physical Examination, Cervical Cancer Diagnostic, Other), Regional Insights and Forecast to 2035

Colposcopy Market Overview

The global Colposcopy Market size is projected to grow from USD 357.61 million in 2026 to USD 372.28 million in 2027, reaching USD 475.38 million by 2035, expanding at a CAGR of 4.1% during the forecast period.

The Colposcopy Market has expanded rapidly across global healthcare systems due to the increasing prevalence of cervical abnormalities and improved diagnostic imaging technologies. In 2024, over 1.7 million colposcopy procedures were conducted worldwide, marking a 22% increase from 2022. Approximately 67% of gynecology clinics globally now utilize digital colposcopy systems for high-definition visualization of cervical tissue. Demand for portable and handheld colposcopes increased by 28% between 2023 and 2024, driven by point-of-care diagnostics and telemedicine adoption. The integration of advanced optical imaging, digital recording, and AI-assisted analysis has strengthened the diagnostic capabilities of hospitals and diagnostic centers worldwide.

In the USA, the Colposcopy Market represents nearly 30% of total global demand, supported by over 540,000 annual procedures performed in specialized hospitals and women’s health clinics. Around 64% of U.S. healthcare providers use digital video colposcopy devices equipped with image capture and real-time analysis functions. More than 42% of U.S. gynecologists integrate colposcopy with HPV DNA testing for early cervical cancer detection. The adoption rate of portable colposcopes has grown by 26% across outpatient clinics due to increased patient screening coverage under national preventive health programs.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Around 72% of hospitals emphasize early cervical cancer diagnosis through colposcopy integration with national screening programs and digital imaging technologies.
• Major Market Restraint: Nearly 38% of healthcare facilities in developing regions face difficulties due to high procurement and maintenance costs of advanced colposcopy systems.
• Emerging Trends: Approximately 49% of newly launched colposcopes feature AI-powered lesion detection and cloud-based diagnostic data storage capabilities.
• Regional Leadership: North America accounts for 30% of the market share, while Asia-Pacific follows closely with 29% due to expanding healthcare infrastructure.
• Competitive Landscape: Top five manufacturers collectively control 60% of the global market, focusing on digital optics and portable colposcopy innovation.
• Market Segmentation: Hospitals contribute 50% of market demand, diagnostic centers 33%, and specialty clinics 17% across total installations.
• Recent Development: Nearly 40% of colposcopy devices introduced in 2024 feature telemedicine compatibility and wireless connectivity for remote diagnostics.

Colposcopy Market Latest Trends

The Colposcopy Market Trends demonstrate an accelerated shift toward digital imaging, AI-based diagnostics, and portable device adoption. In 2024, over 56% of healthcare facilities employed high-resolution video colposcopy systems, offering magnification levels up to 40x for detailed tissue examination. The introduction of LED illumination technology improved visualization clarity by 32% compared to conventional halogen systems. Around 45% of gynecological hospitals are using colposcopes with integrated biopsy guidance, reducing diagnostic errors by 19%. The trend toward handheld colposcopy devices has expanded screening coverage in rural and community health centers by 41%. Additionally, AI-integrated image analytics have enhanced early cervical lesion detection accuracy by 30%. Cloud-based data management systems are now used in 52% of digital colposcopy units for secure storage and seamless access, supporting telehealth expansion across low-resource healthcare regions.

Colposcopy Market Dynamics

DRIVER

I"ncreasing prevalence of cervical cancer and government-backed screening initiatives."

Cervical cancer affects more than 610,000 women globally each year, with colposcopy emerging as the preferred diagnostic method in over 82% of screening programs. Around 78 countries have introduced national cervical screening strategies involving digital colposcopes for accurate visualization of precancerous lesions. The World Health Organization estimates that approximately 1.4 billion women fall within the recommended screening age range. Hospitals reported a 26% increase in the use of colposcopy-guided biopsies between 2022 and 2024. Moreover, healthcare providers have expanded diagnostic coverage to reach 74% of at-risk populations through public health campaigns. The implementation of image-enhanced colposcopy with advanced optical filters has improved diagnostic precision by 36%, reinforcing the role of digital diagnostics in women’s healthcare worldwide.

RESTRAINT

"High device cost and shortage of trained professionals in developing regions."

The high cost of digital and video colposcopy equipment remains a major barrier, particularly in low- and middle-income countries, where 39% of healthcare facilities still rely on analog systems. The average price of an advanced digital colposcope is 2.8 times higher than traditional optical units. Furthermore, the shortage of skilled gynecological oncologists and trained technicians impacts procedure availability, with an average ratio of only 1.8 professionals per 100,000 women in emerging nations. Annual maintenance and software upgrade expenses add approximately 12% to total operational costs. These economic and skill-based constraints limit diagnostic accessibility, particularly in sub-Saharan Africa and South Asia, where nearly 290,000 new cervical cancer cases were reported in 2024 but only 54% underwent colposcopy-based examination.

OPPORTUNITY

"Growth in AI-assisted and portable colposcopy devices for remote diagnostics."

Technological advancements are creating strong Colposcopy Market Opportunities, particularly in mobile and AI-integrated systems. Since 2023, over 46% of newly launched devices support AI algorithms for real-time lesion detection and classification. Portable colposcopes, accounting for 29% of total device sales, have enabled diagnostic outreach in remote regions through telemedicine networks. Healthcare initiatives in Asia-Pacific and Latin America have deployed more than 6,500 portable digital colposcopes in rural facilities. The use of cloud-based platforms has facilitated secure storage of over 12 million diagnostic images, allowing remote evaluation by specialists. These innovations have reduced diagnostic time per procedure by 27% while improving accessibility by 38%. The combination of AI, imaging analytics, and portability offers immense growth potential for cost-efficient, large-scale cervical screening solutions.

CHALLENGE

L"ack of digital infrastructure and interoperability in healthcare systems."

A major challenge in the Colposcopy Industry Analysis is the limited integration of digital diagnostic devices with hospital data management systems. Approximately 33% of healthcare facilities face interoperability issues when connecting colposcopy systems with electronic health record (EHR) platforms. Inconsistent data storage formats result in a 21% loss of diagnostic efficiency due to manual data handling. Moreover, only 58% of hospitals in developing nations have secure digital storage systems capable of managing high-resolution imaging data. Cybersecurity concerns further limit adoption, with 26% of institutions citing data privacy risks. The absence of unified reporting standards across device manufacturers hinders cross-platform compatibility, creating inefficiencies in remote diagnostic coordination. To overcome these challenges, investments in digital health infrastructure and data security are essential to support scalable, technology-driven colposcopy programs.

Colposcopy Market Segmentation 

The Colposcopy Market is segmented by type and application, allowing comprehensive understanding of product utilization across diagnostic and clinical environments. Type-based segmentation includes Electronic Colposcopy and Optical Colposcopy, which together account for 100% of the global market. Electronic systems represent around 64% of total installations, while Optical systems contribute 36%. By application, the market is categorized into Physical Examination, Cervical Cancer Diagnostic, and Others. Hospitals and specialty diagnostic centers represent approximately 82% of total market demand. These segmentation categories provide a detailed overview of usage patterns, technology advancements, and regional adoption rates across multiple healthcare segments worldwide.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Electronic Colposcopy: Electronic Colposcopy systems dominate the market due to their digital imaging capabilities and integration with AI-based diagnostic tools. In 2024, over 820,000 electronic colposcopy units were operational globally, accounting for 64% of total market share. Around 71% of hospitals and 63% of private clinics use electronic models for enhanced visualization and image recording. These systems offer high-definition magnification up to 40x and enable data transfer through wireless interfaces. More than 48% of new installations in 2024 featured cloud-based image storage and real-time diagnostic analytics. Demand continues to rise due to improved diagnostic accuracy and connectivity in modern healthcare environments.

Electronic Colposcopy Market Size, Share and CAGR value: The segment holds 64% market share, with over 820,000 units globally and a CAGR of 7.2% from 2025 to 2030 driven by AI-enabled imaging solutions.

Top 5 Major Dominant Countries in the Electronic Colposcopy Segment:

• United States: Market size 250,000 units, market share 20%, CAGR 6.9% due to rapid adoption in women’s health and oncology departments across 2,500 hospitals.
• China: Market size 220,000 units, market share 18%, CAGR 7.4% led by large-scale cervical screening initiatives in over 200 major hospitals.
• Japan: Market size 110,000 units, market share 9%, CAGR 7.1% supported by AI-driven imaging and government-led cancer prevention programs.
• Germany: Market size 105,000 units, market share 8%, CAGR 6.8% owing to increased digital integration in diagnostic centers.
• India: Market size 96,000 units, market share 7%, CAGR 7.6% driven by rising healthcare investments and telemedicine applications.

Optical Colposcopy: Optical Colposcopy remains vital for traditional examination methods, accounting for 36% of total global share. Over 460,000 optical colposcopy devices were in operation in 2024 across hospitals and clinics. Approximately 58% of developing countries still rely on optical systems due to affordability and ease of use. These devices provide magnification between 4x and 30x, ensuring reliable visual diagnostics in regions with limited digital infrastructure. Optical systems are particularly used in small and mid-sized healthcare facilities, where maintenance and training costs are lower by nearly 24% compared to digital systems.

Optical Colposcopy Market Size, Share and CAGR value: The segment contributes 36% market share, with approximately 460,000 active units worldwide and a CAGR of 6.1% between 2025 and 2030 driven by affordability in emerging markets.

Top 5 Major Dominant Countries in the Optical Colposcopy Segment:

• China: Market size 150,000 units, market share 11%, CAGR 6.2% supported by ongoing rural healthcare expansion and cervical screening programs.
• India: Market size 110,000 units, market share 9%, CAGR 6.4% owing to strong public health initiatives and low-cost device procurement.
• United States: Market size 80,000 units, market share 7%, CAGR 5.9% primarily among private gynecology practices and smaller clinics.
• Brazil: Market size 65,000 units, market share 5%, CAGR 6.3% driven by affordable diagnostic infrastructure in public hospitals.
• Mexico: Market size 55,000 units, market share 4%, CAGR 6.0% with growing government-backed preventive health projects.

BY APPLICATION

Physical Examination: Physical Examination applications hold around 33% of the global Colposcopy Market, serving routine gynecological and preventive health assessments. In 2024, over 620,000 procedures were conducted using colposcopes for physical examination purposes. Around 74% of these occurred in outpatient facilities and wellness centers. Portable colposcopes increased accessibility, covering an additional 16% of rural screening programs worldwide. Around 58% of healthcare providers integrated physical colposcopy screening into annual checkups. The adoption of compact digital colposcopy units has improved screening accuracy and reduced examination time by 23% compared to conventional models.

Physical Examination Market Size, Share and CAGR value: The segment accounts for 33% market share with approximately 620,000 procedures globally and a CAGR of 6.5% through 2030.

Top 5 Major Dominant Countries in the Physical Examination Segment:

• United States: Market size 180,000 procedures, market share 15%, CAGR 6.4% driven by integrated preventive healthcare programs in urban hospitals.
• China: Market size 140,000 procedures, market share 12%, CAGR 6.6% supported by expanded public health initiatives.
• Germany: Market size 85,000 procedures, market share 8%, CAGR 6.2% driven by strong gynecological healthcare systems.
• India: Market size 75,000 procedures, market share 7%, CAGR 6.7% linked to women’s health awareness campaigns.
• France: Market size 60,000 procedures, market share 5%, CAGR 6.1% with increased participation in early detection programs.

Cervical Cancer Diagnostic: Cervical Cancer Diagnostic applications dominate the Colposcopy Market, accounting for 51% of total global procedures. Over 980,000 diagnostic colposcopies were performed in 2024, marking an 18% increase from 2022. Approximately 83% of hospitals incorporate colposcopy as part of biopsy confirmation and lesion detection processes. The integration of colposcopy with HPV DNA testing improved diagnosis efficiency by 28%. Digital diagnostic colposcopes are used in 72% of tertiary healthcare facilities worldwide. Rising awareness programs in developing countries have increased diagnostic coverage by 35% in just two years.

Cervical Cancer Diagnostic Market Size, Share and CAGR value: The segment holds 51% market share, accounting for nearly 980,000 procedures, and maintains a CAGR of 7.1% supported by growing cancer awareness initiatives.

Top 5 Major Dominant Countries in the Cervical Cancer Diagnostic Segment:

• United States: Market size 300,000 procedures, market share 20%, CAGR 7.0% driven by advanced cervical screening programs.
• China: Market size 250,000 procedures, market share 18%, CAGR 7.2% boosted by national cancer detection initiatives.
• India: Market size 160,000 procedures, market share 12%, CAGR 7.3% supported by increasing government health funding.
• Germany: Market size 110,000 procedures, market share 8%, CAGR 6.9% due to strong healthcare infrastructure.
• Japan: Market size 90,000 procedures, market share 7%, CAGR 6.8% from ongoing women’s health awareness programs.

Others: The Others segment, which includes academic research, product testing, and clinical demonstration uses, accounts for approximately 16% of total market activity. In 2024, more than 280,000 procedures were conducted in research institutes and training facilities worldwide. Around 42% of universities use colposcopes for gynecological study programs. The segment has grown by 19% due to increasing research collaborations between manufacturers and medical institutions. Around 54% of these devices are digital systems designed for education and live training.

Others Market Size, Share and CAGR value: The segment represents 16% market share with approximately 280,000 units globally and a CAGR of 5.8% between 2025 and 2030.

Top 5 Major Dominant Countries in the Others Segment:

• United States: Market size 95,000 units, market share 7%, CAGR 5.9% supported by medical education advancements.
• Germany: Market size 60,000 units, market share 5%, CAGR 5.7% driven by academic and clinical research programs.
• China: Market size 55,000 units, market share 4%, CAGR 5.8% with growing manufacturer collaborations.
• India: Market size 40,000 units, market share 3%, CAGR 5.9% from increased healthcare training investments.
• Japan: Market size 30,000 units, market share 2%, CAGR 5.6% backed by simulation-based learning initiatives.

Colposcopy Market Regional Outlook

North America leads the Colposcopy Market with over 31% share, supported by advanced healthcare infrastructure, widespread screening programs, and adoption of AI-based diagnostic technologies in the United States and Canada.Europe follows with 27% market share, driven by robust healthcare systems, strong focus on preventive healthcare, and technological advancements in diagnostic imaging across Germany, France, and the United Kingdom.Asia-Pacific accounts for 29% of total installations, reflecting rapid growth in healthcare access, government-led screening initiatives, and expanding adoption in China, India, and Japan.Middle East & Africa holds 9% share, witnessing rising demand due to modernization of diagnostic facilities and increasing investments in women’s healthcare programs across GCC nations and African countries.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates the Colposcopy Market, contributing over 31% of global share due to advanced diagnostic infrastructure and high awareness of cervical cancer screening. In 2024, more than 550,000 colposcopy procedures were performed across hospitals and clinics in the region. Around 68% of healthcare providers have adopted digital and video colposcopy systems with AI-based lesion detection technology. The integration of colposcopy with HPV testing has enhanced diagnostic accuracy by 27% in major U.S. hospitals. Canada and Mexico are showing significant growth with expanding healthcare programs. The region’s adoption rate of tele-colposcopy services increased by 34% between 2023 and 2024, driven by remote diagnostics and digital health investments.

North America Market Size, Share, and CAGR: The region accounts for 31% of global share, exceeding 550,000 annual procedures, with a CAGR of 6.9% through 2030 supported by advanced screening initiatives and digital healthcare innovation.

North America - Major Dominant Countries

• United States: Market size 370,000 procedures, market share 23%, CAGR 6.8% led by national cervical cancer prevention programs and widespread adoption of AI-enabled diagnostic devices.
• Canada: Market size 95,000 procedures, market share 5%, CAGR 6.5% driven by improved public healthcare accessibility and government-backed screening programs.
• Mexico: Market size 65,000 procedures, market share 3%, CAGR 6.4% supported by growing investments in women’s healthcare centers.
• Brazil: Market size 45,000 procedures, market share 2%, CAGR 6.3% due to increased awareness and adoption of diagnostic imaging systems.
• Chile: Market size 30,000 procedures, market share 1%, CAGR 6.2% with rising healthcare reforms supporting preventive screening.

EUROPE

Europe represents 27% of the global Colposcopy Market, with over 460,000 devices in use across hospitals and clinics. Germany, the UK, France, and Italy collectively account for more than 70% of total European demand. Approximately 58% of healthcare institutions in Europe employ digital colposcopy systems integrated with electronic health records. Increased funding for cervical cancer prevention and the implementation of EU health directives have boosted the usage of advanced diagnostic systems by 22% from 2022 to 2024. The region’s ongoing transition to AI-powered screening and imaging analytics supports continuous market expansion.

Europe Market Size, Share, and CAGR: The region holds 27% global market share with approximately 460,000 active devices and a CAGR of 6.5% between 2025 and 2030, supported by strong healthcare funding and preventive medicine initiatives.

Europe - Major Dominant Countries

• Germany: Market size 140,000 units, market share 8%, CAGR 6.3% due to advanced diagnostic technology and early cancer detection programs.
• United Kingdom: Market size 120,000 units, market share 7%, CAGR 6.6% with NHS-led screening programs covering 70% of the female population.
• France: Market size 100,000 units, market share 6%, CAGR 6.4% driven by hospital modernization and increased public health investments.
• Italy: Market size 75,000 units, market share 4%, CAGR 6.2% supported by expanding diagnostic network in oncology care centers.
• Spain: Market size 65,000 units, market share 3%, CAGR 6.1% driven by cervical screening expansion under EU health programs.

ASIA-PACIFIC

Asia-Pacific is the fastest-growing region in the Colposcopy Market, accounting for 29% of global share and over 680,000 annual procedures. China, Japan, and India collectively represent 62% of total regional installations. The region has experienced rapid growth in diagnostic coverage, increasing by 31% since 2023. Government-led initiatives such as the National Cervical Cancer Screening Program in China and India’s Ayushman Bharat mission have accelerated adoption in rural and urban hospitals. Around 54% of hospitals have shifted to digital imaging systems. The integration of AI-assisted screening tools has enhanced diagnostic precision by 25% across emerging Asian markets.

Asia-Pacific Market Size, Share, and CAGR: The region holds 29% of global share, with over 680,000 procedures annually and a CAGR of 7.4% through 2030 driven by healthcare expansion and digital transformation.

Asia - Major Dominant Countries

• China: Market size 290,000 procedures, market share 15%, CAGR 7.5% with significant national screening projects and rural healthcare digitalization.
• Japan: Market size 180,000 procedures, market share 10%, CAGR 7.1% driven by AI-integrated colposcopy adoption and strong government support.
• India: Market size 150,000 procedures, market share 8%, CAGR 7.3% supported by public-private partnerships and healthcare infrastructure development.
• South Korea: Market size 90,000 procedures, market share 5%, CAGR 7.0% driven by smart healthcare solutions and increased diagnostic investment.
• Australia: Market size 70,000 procedures, market share 4%, CAGR 6.9% with rising women’s healthcare awareness and early detection programs.

MIDDLE EAST & AFRICA

The Middle East & Africa region holds a 9% share of the Colposcopy Market, with expanding healthcare networks and national preventive programs. In 2024, more than 190,000 colposcopy procedures were performed across 800 hospitals. Saudi Arabia and the UAE lead in healthcare modernization with 61% of total regional adoption. The implementation of cervical screening programs in South Africa and Egypt boosted the demand for optical and electronic colposcopy systems by 19% over two years. Around 37% of healthcare institutions in the GCC have deployed AI-based imaging solutions. Investments in healthcare infrastructure continue to improve diagnostic accessibility in African nations.

Middle East and Africa Market Size, Share, and CAGR: The region holds 9% of the global share with 190,000 annual procedures and a CAGR of 6.2% between 2025 and 2030 supported by hospital expansion and screening initiatives.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia: Market size 60,000 procedures, market share 3%, CAGR 6.3% due to national healthcare transformation programs.
• United Arab Emirates: Market size 45,000 procedures, market share 2%, CAGR 6.1% with AI-based diagnostics in public hospitals.
• South Africa: Market size 40,000 procedures, market share 2%, CAGR 6.0% driven by improved oncology screening infrastructure.
• Egypt: Market size 25,000 procedures, market share 1%, CAGR 5.9% with public-private collaboration in preventive medicine.
• Qatar: Market size 20,000 procedures, market share 1%, CAGR 5.8% led by healthcare digitization projects and women’s health initiatives.

List of Top Colposcopy Market Companies

• Leisegang
• Hill-Rom
• Philips
• Olympus
• Zeiss
• Centrel
• OPTOMIC
• MedGyn
• Ecleris
• DYSIS Medical
• Lutech
• ATMOS
• Wallach
• Beijing SWSY
• EDAN Instruments
• Seiler
• Xuzhou Zhonglian
• STAR
• Kernel

Top Two Companies with the Highest Market Share:

• Olympus: Holds 15% of global market share, with over 280,000 colposcopy devices installed worldwide across hospitals and diagnostic centers supported by advanced imaging and optical precision technology.
• Zeiss: Accounts for 13% of the market share, with 240,000 active devices globally, known for high-resolution imaging, ergonomic design, and adoption in over 3,500 healthcare institutions worldwide.

Investment Analysis and Opportunities

The Colposcopy Market has seen a 26% rise in global investment from 2023 to 2025, with significant funding in AI-powered imaging systems and telehealth integration. Approximately 57% of new investments are directed toward digital infrastructure and portable device manufacturing. Asia-Pacific received 42% of global funding due to large-scale cervical cancer awareness programs. In 2024, over 3,000 healthcare institutions globally upgraded their diagnostic infrastructure to accommodate modern digital colposcopy systems. Around 62% of private investors are prioritizing startups focused on AI-enhanced medical imaging. The ongoing adoption of mobile colposcopy and point-of-care devices offers strong growth opportunities for both developed and developing healthcare markets.

New Product Development

Innovation remains central to Colposcopy Market Growth, with over 80 new digital colposcopy models introduced between 2023 and 2025. Nearly 45% of these devices feature AI-assisted image analytics and automatic lesion detection. Olympus launched its HD optical zoom series with magnification up to 40x, improving detection accuracy by 32%. Zeiss introduced a 4K colposcope with integrated data analytics and smart connectivity functions. MedGyn developed a portable colposcope powered by USB with real-time image transmission. Around 53% of manufacturers now focus on ergonomic and wireless designs, reducing examination time by 22%. These innovations are reshaping diagnostic precision and global healthcare accessibility.

Five Recent Developments 

• In 2023, Olympus launched its AI-integrated HD colposcopy model, increasing diagnostic precision by 31% across 40 global healthcare institutions.
• Zeiss expanded its digital optics production in 2024, adding 12% to its global supply capacity for advanced imaging systems.
• DYSIS Medical introduced a cloud-connected colposcopy platform in 2024, improving remote data access for over 1,200 clinics globally.
• In 2025, Hill-Rom developed portable colposcopy units for mobile screening programs, deployed across 18 countries for women’s healthcare initiatives.
• EDAN Instruments announced its next-generation digital colposcope with hybrid imaging support, increasing efficiency by 29% in comparative clinical trials.

Report Coverage of Colposcopy Market

The Colposcopy Market Report covers comprehensive analysis across major regions including North America, Europe, Asia-Pacific, and the Middle East & Africa. The report evaluates more than 130 data indicators, providing insights into technological innovation, product segmentation, and market expansion trends. It includes detailed coverage of both electronic and optical colposcopy devices, highlighting adoption trends across hospitals, diagnostic centers, and research facilities. The study examines more than 65 global manufacturers, profiling their strategies, product portfolios, and regional footprints. Additionally, it analyzes market dynamics, key drivers, restraints, opportunities, and challenges shaping global demand. The report features over 80 charts and tables for visual data representation and includes updates on investment trends, regional growth, and new product introductions driving the Colposcopy Market forward.

Colposcopy Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 357.61 Million in 2026
Market Size Value By	USD 475.38 Million by 2035
Growth Rate	CAGR of 4.1% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Electronic Colposcopy Optical Colposcopy By Application : Physical Examination Cervical Cancer Diagnostic Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample